Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer

by Lambertini, Matteo, Viglietti, Giulia
Published in Oncotarget (2019)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

by Lambertini, Matteo, Viglietti, Giulia, de Azambuja, Evandro
Published in ESMO Open (2018)

Oncofertility counselling in premenopausal women with HER2-positive breast cancer

by Lambertini, Matteo, Demeestere, Isabelle, Viglietti, Giulia, de Azambuja, Evandro
Published in Oncotarget (2019)

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

by Lambertini, Matteo, Richard, François, Nguyen, Bastien, Viglietti, Giulia, Villarreal-Garza, Cynthia
Published in Clin Med Insights Reprod Health (2019)

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis

by Poggio, Francesca, Bruzzone, Marco, Ceppi, Marcello, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco, Viglietti, Giulia, Del Mastro, Lucia, de Azambuja, Evandro, Lambertini, Matteo
Published in ESMO Open (2018)